CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 58 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $166,249 | -23.5% | 39,583 | +9.5% | 0.00% | – |
| Q4 2022 | $217,280 | +62.1% | 36,153 | +57.2% | 0.00% | – |
| Q3 2022 | $134,000 | +45.7% | 22,999 | +49.7% | 0.00% | – |
| Q2 2022 | $92,000 | +27.8% | 15,365 | 0.0% | 0.00% | – |
| Q1 2022 | $72,000 | +89.5% | 15,365 | 0.0% | 0.00% | – |
| Q4 2021 | $38,000 | -15.6% | 15,365 | 0.0% | 0.00% | – |
| Q3 2021 | $45,000 | +18.4% | 15,365 | 0.0% | 0.00% | – |
| Q2 2021 | $38,000 | -15.6% | 15,365 | 0.0% | 0.00% | – |
| Q1 2021 | $45,000 | -8.2% | 15,365 | 0.0% | 0.00% | – |
| Q4 2020 | $49,000 | +48.5% | 15,365 | 0.0% | 0.00% | – |
| Q3 2020 | $33,000 | +83.3% | 15,365 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +28.6% | 15,365 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | – | 15,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |